Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013, Article ID 241347, 9 pages
http://dx.doi.org/10.1155/2013/241347
Research Article

Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register

1Division of Health Economics, Department of Clinical Sciences, Malmö University Hospital, Lund University, 20502 Malmö, Sweden
2Health Economics & Management, Institute of Economic Research, Lund University, 22007 Lund, Sweden
3Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran 141556447, Iran
4School of Public Health, University of Sydney, Sydney, NSW 2006, Australia
5Department of Economics, Lund University, 22363 Lund, Sweden
6Department of Clinical Sciences, Malmö University Hospital, Lund University, 20502 Malmö, Sweden
7Department of Medicine, Sahlgrenska University Hospital, University of Gothenburg, 41345 Göteborg, Sweden

Received 24 August 2012; Accepted 31 January 2013

Academic Editor: T. S. Kern

Copyright © 2013 Aliasghar Ahmad Kiadaliri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Charpentier, N. Genès, L. Vaur et al., “Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey,” Diabetes and Metabolism, vol. 29, no. 2 I, pp. 152–158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Imazu, K. Sumii, H. Yamamoto et al., “Influence of type 2 diabetes mellitus on cardiovascular disease mortality: findings from the Hawaii-Los Angeles-Hiroshima study,” Diabetes Research and Clinical Practice, vol. 57, no. 1, pp. 61–69, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Gu, C. C. Cowie, and M. I. Harris, “Mortality in adults with and without diabetes in a National cohort of the U.S. Population, 1971–1993,” Diabetes Care, vol. 21, no. 7, pp. 1138–1145, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Gaede, P. Vedel, N. Larsen, G. V. Jensen, H. H. Parving, and O. Pedersen, “Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 348, no. 5, pp. 383–393, 2003. View at Publisher · View at Google Scholar
  5. G. Panzram, “Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus,” Diabetologia, vol. 30, no. 3, pp. 123–131, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. W. A. Muller, “Diabetes mellitus—long time survival,” Journal of Insurance Medicine, vol. 30, no. 1, pp. 17–27, 1998. View at Google Scholar
  7. J. Stamler, O. Vaccaro, J. D. Neaton, and D. Wentworth, “Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial,” Diabetes Care, vol. 16, no. 2, pp. 434–444, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Eeg-Olofsson, J. Cederholm, P. M. Nilsson et al., “Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients,” Diabetologia, vol. 52, no. 1, pp. 65–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. M. Nilsson, J. Cederholm, K. Eeg-Olofsson et al., “Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 16, no. 4, pp. 506–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Pfister, R. Cairns, E. Erdmann, and C. A. Schneider, “A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study,” International Journal of Cardiology, vol. 162, no. 2, pp. 112–116, 2013. View at Publisher · View at Google Scholar
  11. B. Zethelius, B. Eliasson, K. Eeg-Olofsson, A. M. Svensson, S. Gudbjörnsdottir, and J. Cederholm, “A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR),” Diabetes Research and Clinical Practice, vol. 93, no. 2, pp. 276–284, 2011. View at Publisher · View at Google Scholar
  12. N. Chaturvedi, L. K. Stevens, J. H. Fuller, E. T. Lee, and M. Lu, “Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes: the WHO multinational study of vascular disease in diabetes,” Diabetologia, vol. 44, supplement 2, pp. S65–S71, 2001. View at Publisher · View at Google Scholar
  13. P. M. Clarke, A. M. Gray, A. Briggs et al., “A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model,” Diabetologia, vol. 47, no. 10, pp. 1747–1759, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. R. J. Stevens, V. Kothari, A. I. Adler, I. M. Stratton, and R. R. Holman, “The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56),” Clinical Science, vol. 101, no. 6, pp. 671–679, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Cederholm, K. Eeg-Olofsson, B. Eliasson, B. Zethelius, P. M. Nilsson, and S. Gudbjörnsdottir, “Risk prediction of cardiovascular disease in type 2 diabetes,” Diabetes Care, vol. 31, no. 10, pp. 2038–2043, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. J. Palmer, S. Roze, W. J. Valentine et al., “Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting,” Diabetes Care, vol. 30, no. 6, pp. 1638–1646, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. National Collaborating Centre for Chronic Conditions, “Type 2 diabetes: National Clinical Guideline for Management in Primary and Secondary Care (Update),” Royal College of Physicians, London, UK, 2008. View at Publisher · View at Google Scholar
  18. J. Leal, A. M. Gray, and P. M. Clarke, “Development of life-expectancy tables for people with type 2 diabetes,” European Heart Journal, vol. 30, no. 7, pp. 834–839, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Drummond, M. Barbieri, J. Cook et al., “Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report,” Value in Health, vol. 12, no. 4, pp. 409–418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. Finucane, G. A. Stevens, M. J. Cowan et al., “National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants,” The Lancet, vol. 377, no. 9765, pp. 557–567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Danaei, M. M. Finucane, J. K. Lin et al., “National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants,” The Lancet, vol. 377, no. 9765, pp. 568–577, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Gudbjörnsdottir, J. Cederholm, P. M. Nilsson, and B. Eliasson, “The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care,” Diabetes Care, vol. 26, no. 4, pp. 1270–1276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Hoelzel, C. Weykamp, J. O. Jeppsson et al., “IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study,” Clinical Chemistry, vol. 50, no. 1, pp. 166–174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. National Board on Health and Welfare, Stockholm, Sweden, 1999.
  25. M. Arellano and O. Bover, “Another look at the instrumental variable estimation of error-components models,” Journal of Econometrics, vol. 68, no. 1, pp. 29–51, 1995. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  26. R. Blundell and S. Bond, “Initial conditions and moment restrictions in dynamic panel data models,” Journal of Econometrics, vol. 87, no. 1, pp. 115–143, 1998. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  27. L. P. Hansen, “Large sample properties of generalized method of moments estimators,” Econometrica, vol. 50, no. 4, pp. 1029–1054, 1982. View at Publisher · View at Google Scholar · View at Zentralblatt MATH
  28. D. Roodman, “How to do xtabond2: an introduction to difference and system GMM in Stata,” The Stata Journal, vol. 9, no. 1, pp. 86–136, 2009. View at Google Scholar · View at Scopus
  29. StataCorp., Stata Statistical Software: Release 10, StataCorp LP, College Station, Tex, USA, 2007.
  30. E. W. Steyerberg, Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating, Springer, New York, NY, USA, 2009.
  31. D. G. Altman and P. Royston, “What do we mean by validating a prognostic model?” Statistics in Medicine, vol. 19, no. 4, pp. 453–473, 2000. View at Publisher · View at Google Scholar
  32. J. P. C. Kleijnen, “Verification and validation of simulation models,” European Journal of Operational Research, vol. 82, no. 1, pp. 145–162, 1995. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  33. R. C. Fair, “Evaluating the predictive accuracy of models,” in Handbook of Econometrics, Z. Griliches and M. D. Intriligator, Eds., vol. 3, pp. 1979–1995, Elsevier Science, North Holland, The Netherlands, 1986. View at Publisher · View at Google Scholar · View at Zentralblatt MATH
  34. S. Nickell, “Biases in dynamic models with fixed effects,” Econometrica, vol. 49, no. 6, pp. 1417–1426, 1981. View at Publisher · View at Google Scholar · View at Zentralblatt MATH
  35. A. Trognon, “Miscellaneous asymptotic properties of ordinary least squares and maximum likelihood estimators in dynamic error components models,” Annales De L'INSEE, vol. 30-31, pp. 631–657, 1978. View at Google Scholar
  36. B. Lokshin, “Further results on bias in dynamic unbalanced panel data models with an application to firm R&D investment,” UNU-MERIT Working Papers, 2008. View at Google Scholar
  37. A. Bhargava, “A longitudinal analysis of the risk factors for diabetes and coronary heart disease in the Framingham Offspring Study,” Population Health Metrics, vol. 1, article 3, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. US Department of Health and Human Services, “The health benefits of smoking cessation: a report of the surgeon general,” DHHS Publication CDC 90-8416, Office on Smoking and Health, Rockville, Md, USA, 2003. View at Google Scholar
  39. T. Mizoue, R. Ueda, N. Tokui, Y. Hino, and T. Yoshimura, “Body mass decrease after initial gain following smoking cessation,” International Journal of Epidemiology, vol. 27, no. 6, pp. 984–988, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Eliasson, K. Eeg-Olofsson, J. Cederholm, P. M. Nilsson, and S. Gudbjörnsdóttir, “Antihyperglycaemic treatment oftype 2diabetes: results from anational diabetes register,” Diabetes and Metabolism, vol. 33, no. 4, pp. 269–276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Fhärm, Treatment of cardiovascular risk factors in type 2 diabetes—time trends and clinical practice [Doctoral thesis], Umeå university, 2009.
  42. M. Ridderstråle, S. Gudbjörnsdottir, B. Eliasson et al., “Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register,” Journal of Internal Medicine, vol. 259, pp. 314–322, 2006. View at Publisher · View at Google Scholar